We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$269M
AUM Growth
-$24.5M
Cap. Flow
-$35.3M
Cap. Flow %
-13.1%
Top 10 Hldgs %
26.19%
Holding
93
New
19
Increased
21
Reduced
26
Closed
25

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.83M
2
UHS icon
Universal Health Services
UHS
+$6.41M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.69M
4
VTRS icon
Viatris
VTRS
+$4.59M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.18M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$8.51M
2
A icon
Agilent Technologies
A
+$6.74M
3
GILD icon
Gilead Sciences
GILD
+$6.48M
4
RVTY icon
Revvity
RVTY
+$6.21M
5
AET
Aetna Inc
AET
+$6.01M

Sector Composition

Rank Sector Weight
1 Healthcare 92.73%
2 Financials 1.34%
3 Energy 1.14%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHE icon
51
Chemed
CHE
$7.18B
$2.43M 0.9%
10,000
-2,500
-20% -$568K
CLVS
52
DELISTED
Clovis Oncology, Inc.
CLVS
$2.38M 0.88%
35,000
+5,000
+17% +$350K
EW icon
53
Edwards Lifesciences
EW
$53B
$2.25M 0.84%
+60,000
New +$2.2M
AVXS
54
DELISTED
AveXis, Inc. Common Stock
AVXS
$2.21M 0.82%
+20,000
New +$2.01M
KND
55
DELISTED
Kindred Healthcare
KND
$2.18M 0.81%
225,000
+199,037
+767% +$1.48M
BHC icon
56
Bausch Health
BHC
$2.37B
$2.08M 0.77%
100,000
-75,000
-43% -$1.19M
TSRO
57
DELISTED
TESARO, Inc.
TSRO
$2.07M 0.77%
25,000
+15,000
+150% +$1.47M
DPLO
58
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$2.01M 0.74%
+100,000
New +$1.97M
ACAD icon
59
Acadia Pharmaceuticals
ACAD
$5.06B
$1.96M 0.73%
65,000
-55,000
-46% -$1.76M
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.95M 0.72%
40,000
+15,000
+60% +$759K
SRPT icon
61
Sarepta Therapeutics
SRPT
$1.81B
$1.67M 0.62%
+30,000
New +$1.59M
JUNO
62
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.6M 0.59%
35,000
-20,000
-36% -$998K
BPMC
63
DELISTED
Blueprint Medicines
BPMC
$1.51M 0.56%
+20,000
New +$1.41M
LOXO
64
DELISTED
Loxo Oncology, Inc
LOXO
$1.47M 0.55%
17,500
-7,500
-30% -$625K
SGEN
65
DELISTED
Seagen Inc. Common Stock
SGEN
$1.47M 0.55%
27,500
-2,500
-8% -$146K
AGIO icon
66
Agios Pharmaceuticals
AGIO
$1.95B
$1.14M 0.42%
+20,019
New +$1.26M
A icon
67
Agilent Technologies
A
$42B
– –
-105,000
Closed -$6.74M
AMED
68
DELISTED
Amedisys
AMED
– –
-55,000
Closed -$3.08M
BRKR icon
69
Bruker
BRKR
$8.58B
– –
-50,000
Closed -$1.49M
DGX icon
70
Quest Diagnostics
DGX
$26.2B
– –
-20,000
Closed -$1.87M
DHR icon
71
Danaher
DHR
$147B
– –
-62,040
Closed -$4.72M
EHC icon
72
Encompass Health
EHC
$12.5B
– –
-63,996
Closed -$2.36M
GILD icon
73
Gilead Sciences
GILD
$165B
– –
-80,000
Closed -$6.48M
IDXX icon
74
Idexx Laboratories
IDXX
$46.9B
– –
-17,500
Closed -$2.72M
MTD icon
75
Mettler-Toledo International
MTD
$28.6B
– –
-3,200
Closed -$2M
1 2
3
4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q4 2017 Portfolio in Review

As of Q4 2017, Sivik Global Healthcare held 93 positions worth $269M, down 8.3% from $294M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sivik Global Healthcare withdrew a net $35.3M in Q4 2017, closing 25 positions and reducing 26 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $8.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 87% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in HCA Healthcare worth $7.47M.

  • Sivik Global Healthcare's largest Q4 2017 buy was HCA Healthcare: 85,000 shares worth $7.47M.
  • Sivik Global Healthcare added most to Teva Pharmaceuticals in Q4 2017, an estimated $2.63M increase.
  • Sivik Global Healthcare's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $6.01M.
  • Sivik Global Healthcare fully exited Thermo Fisher Scientific in Q4 2017, selling an estimated $8.51M.
  • Sivik Global Healthcare's ten largest holdings make up 26% of its $269M portfolio in Q4 2017.
  • Sivik Global Healthcare opened 19 new positions and closed 25 in Q4 2017.
  • Sivik Global Healthcare's portfolio value fell 8.3% quarter-over-quarter to $269M.

Based on Sivik Global Healthcare's 13F filing for Q4 2017, filed 8 Feb 2018.